Home›Search›Signal Transduction and Targeted Therapy

Signal Transduction and Targeted Therapy

Springer Nature · United Kingdom · Est. 1975

ISSN2059-3635

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 25% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

17.74

H-Indexi

263

SNIPi

7.309

Total Worksi

2,708

Total Citationsi

283,102

2yr Mean Citednessi

42.32

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Signal Transduction and Targeted Therapy is an international, peer-reviewed, open-access journal that publishes original research articles and review articles related to all aspects of signal transduction in physiological and pathological processes, as well as signal transduction-targeted therapeutics in the form of biological agents and small molecular drugs used to treat human diseases such as cancer, autoimmune disorders, and others. This journal focuses on cutting-edge advances both experimentally and clinically.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1975

Annual Volume~ 422 articles / year

StatusActive (last: 2026)

Total Publications2,708

Publisher OrgSpringer Nature

OA Since2015

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

9/11 · 82%

✅

Do you know the journal / publisher?

Springer Nature

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2059-3635

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

8.8k

2019

301

52k

2020

443

64k

2021

403

58k

2022

469

63k

2023

370

40k

2024

428

16k

2025

353

988

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ1

GeneticsQ1

Subject Classification

Web of Science Categories

Biochemistry & Molecular BiologyCell Biology

Scopus Categories

GeneticsCancer Research

Research Topics (OpenAlex)

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCancer Immunotherapy and BiomarkersRNA modifications and cancerImmune Cell Function and InteractionCAR-T cell therapy researchEpigenetics and DNA MethylationImmune cells in cancerCancer, Hypoxia, and MetabolismImmunotherapy and Immune Responses

Frequently asked questions about Signal Transduction and Targeted Therapy

Is Signal Transduction and Targeted Therapy a predatory journal?

PubScope has no integrity flags on record for Signal Transduction and Targeted Therapy: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Signal Transduction and Targeted Therapy?

Signal Transduction and Targeted Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 42.32.

Is Signal Transduction and Targeted Therapy indexed in Scopus and Web of Science?

Signal Transduction and Targeted Therapy is indexed in Web of Science, Scopus, DOAJ.